WCBP 2025
WCBP Symposium series is the pre-eminent conference addressing the analytical development/regulatory control interface for biotechnology derived health intervention products.
Date: January 28-30, 2025
Location: The Mayflower Hotel, Washington D.C.
Booth: 14
JOIN US!
Come join us and learn how Catalent Biologics can support your CMC strategy and accelerate your therapies’ path to patients via our comprehensive biologics analytical service offering.
Connect with our industry-leading experts to explore how our extensive characterization and analytical services can support you throughout your development life cycle.
Complete the form to schedule a meeting with a specialist.
SPEAKING PRESENTATIONS
Title: Evaluating the Stability of Monoclonal Antibodies: The Role of Forced Degradation Conditions in Method Development, Manufacturability, Aggregation, and other Critical Quality Attributes
Speaker: Brent Kennedy – Manager, Biologics Analytical Services, Catalent Biologics
Time: 12:25 pm
Date: January 29, 2025
Location: Chinese Room
Brent Kennedy
Manager
Biologics Analytical Services
Catalent Biologics
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually.
